Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2011 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (286)	11/7/2011 3:44:56 PM
From: Chris08	1 Recommendation Respond to of 400

More mouth flapping in Cannes, I think, than in Athens.

To: BulbaMan who wrote (286)	11/18/2011 5:17:00 PM
From: BulbaMan	1 Recommendation Read Replies (2) \| Respond to of 400

11/18/11 Contest Update Am back from honeymooning in NYC. Judging by the crowd at Mario Batali’s Babbo, the bankers had quickly forgiven Batali for comparing them to Hitler and Stalin a week earlier. Who was it that said: “It’s the pasta, stupid!”? Among NYC’s other highlights, the Cattelan exhibit at the Guggenheim is over the top (or, more literally, hung from the top). If you’re visiting NYC before the exhibit closes (1/22/12) and want a mind-blowing experience, check it out. And, as always, the market was good for a few thrills. At Friday’s close, the NBI was down -1.23% YTD (vs. up 2.77% YTD two weeks ago) and the Contest median was down -9.49% YTD (vs. down -.85% YTD two weeks ago). The Nasdaq Composite Index was down -3.03% YTD (vs. up 1.25% YTD two weeks ago). JIBAC’s portfolio (up 51.88% YTD) remains our leader, with MCBIO’s portfolio (up 38.51% YTD) moving into second place and ROCKY’s’s portfolio (up 34.28% YTD) falling back to third place. At Friday's close, just 10 of the 38 Contest portfolios were in the black, while the same 10 were beating the NBI. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the prior two weeks (foreign stock prices are not converted to US$ in these two tables). Portfolio adjustments: None Have a wonderful weekend biotechies! (All corrections, especially adjustments for splits, greatly appreciated.) 11/18/11 Rank Name Profit/Loss 1 JIBAC 51,884 2 MCBIO 38,513 3 ROCKY 34,277 4 FIB 24,128 5 GENE 22,599 6 RRGE 17,625 7 JULIUS 10,129 8 IJF 3,692 9 WILDER 3,136 10 BIOFISH 33 Two Week's Top 5 Gainers Symbol 11/4 11/18 % change IDIX 5.65 7.41 31.15% DNDN 6.69 8.34 24.66% SKBI 2.45 2.98 21.63% MYG.TO 0.24 0.28 16.67% TSRX 6.80 7.85 15.44% Two Week's Top 5 Losers Symbol 11/4 11/18 % change PSDV 4.14 1.26 -69.57% TRGT 19.25 7.30 -62.08% ROSG 0.68 0.42 -38.24% GERN 2.38 1.50 -36.97% IDRA 1.92 1.25 -34.90%